{"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"4"},{"groupId":"BG005","value":"6"},{"groupId":"BG006","value":"13"},{"groupId":"BG007","value":"8"},{"groupId":"BG008","value":"15"},{"groupId":"BG009","value":"3"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"78"}],"units":"Participants"}],"groups":[{"description":"Participants received pembrolizumab 200 mg IV every 3 weeks in combination with of PLX3397 at 400 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 200 mg in the evening)..","id":"BG000","title":"Dose Escalation: 400 mg/Day"},{"description":"Participants received pembrolizumab 200 mg IV every 3 weeks in combination with of PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG001","title":"Dose Escalation: 600 mg/Day"},{"description":"Participants with liver metastases received pembrolizumab 200 mg IV every 3 weeks in combination with of PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG002","title":"Dose Escalation: 600 mg/Day (Liver Metastases"},{"description":"Participants with no liver metastases received pembrolizumab 200 mg IV every 3 weeks in combination with of PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG003","title":"Dose Escalation: 600 mg/Day (no Liver Metastases)"},{"description":"Participants with liver metastases received pembrolizumab 200 mg IV every 3 weeks in combination with of PLX3397 at 800 mg/day (administered twice daily \\[BID\\] as a split dose of 400 mg in the morning and 400 mg in the evening).","id":"BG004","title":"Dose Escalation: 800 mg/Day (Liver Metastases)"},{"description":"Participants with no liver metastases received pembrolizumab 200 mg IV every 3 weeks in combination with of PLX3397 at 800 mg/day (administered twice daily \\[BID\\] as a split dose of 400 mg in the morning and 400 mg in the evening)..","id":"BG005","title":"Dose Escalation: 800 mg/Day (no Liver Metastases)"},{"description":"Participants with melanoma received pembrolizumab 200 mg IV every 3 weeks in combination with PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG006","title":"Dose Expansion: Melanoma"},{"description":"Participants with NSCLC received pembrolizumab 200 mg IV every 3 weeks in combination with PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG007","title":"Dose Expansion: NSCLC"},{"description":"Participants with ovarian cancer received pembrolizumab 200 mg IV every 3 weeks in combination with PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG008","title":"Dose Expansion: Ovarian Cancer"},{"description":"Participants with SCCHN received pembrolizumab 200 mg IV every 3 weeks in combination with PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG009","title":"Dose Expansion: SCCHN"},{"description":"Participants with GIST received pembrolizumab 200 mg IV every 3 weeks in combination with PLX3397 at 600 mg/day (administered twice daily \\[BID\\] as a split dose of 200 mg in the morning and 400 mg in the evening).","id":"BG010","title":"Dose Expansion: GIST"},{"description":"Total of all reporting groups","id":"BG011","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"9"},{"groupId":"BG007","value":"6"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"2"},{"groupId":"BG010","value":"4"},{"groupId":"BG011","value":"50"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"4"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"2"},{"groupId":"BG008","value":"5"},{"groupId":"BG009","value":"1"},{"groupId":"BG010","value":"2"},{"groupId":"BG011","value":"28"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.6","value":"64.5"},{"groupId":"BG001","spread":"10.2","value":"54.7"},{"groupId":"BG002","spread":"17.0","value":"51.1"},{"groupId":"BG003","spread":"10.9","value":"55.9"},{"groupId":"BG004","spread":"5.3","value":"72.0"},{"groupId":"BG005","spread":"8.7","value":"61.7"},{"groupId":"BG006","spread":"8.3","value":"61.8"},{"groupId":"BG007","spread":"11.3","value":"57.0"},{"groupId":"BG008","spread":"12.5","value":"60.4"},{"groupId":"BG009","spread":"16.3","value":"52.7"},{"groupId":"BG010","spread":"8.8","value":"59.7"},{"groupId":"BG011","spread":"11.5","value":"59.3"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"15"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"2"},{"groupId":"BG011","value":"41"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"9"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"3"},{"groupId":"BG010","value":"4"},{"groupId":"BG011","value":"37"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"1"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"2"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"1"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"1"},{"groupId":"BG011","value":"5"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"8"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"12"},{"groupId":"BG007","value":"6"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"3"},{"groupId":"BG010","value":"5"},{"groupId":"BG011","value":"68"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"},{"groupId":"BG011","value":"3"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"9"},{"groupId":"BG004","value":"4"},{"groupId":"BG005","value":"6"},{"groupId":"BG006","value":"13"},{"groupId":"BG007","value":"8"},{"groupId":"BG008","value":"15"},{"groupId":"BG009","value":"3"},{"groupId":"BG010","value":"6"},{"groupId":"BG011","value":"78"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}